# SBI Pharmaceuticals

Source: https://onco.cc/companies/sbi-pharmaceuticals/  
OnCo record `sbi-pharmaceuticals` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

SBI Pharmaceuticals is the Tokyo company behind 5-aminolevulinic acid products in Japan, including Alaglio, which makes bladder tumours glow during cystoscopy so surgeons can see and remove them.

## Summary

SBI Pharmaceuticals, part of Japan's SBI group and founded in 2011, develops medicines and supplements based on 5-aminolevulinic acid. Its Alaglio was approved in Japan for photodynamic diagnosis of bladder cancer during transurethral resection and for glioma surgery, and its Canadian arm SBI ALApharma Canada ran phase 3 trials to bring the bladder cancer indication to North America, registered on ClinicalTrials.gov.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: SBI ALApharma Canada, Inc.; SBI ALApharma; SBIファーマ
- Tags: ctgov-sponsor
- HQ: Tokyo
- Type: pharma
- Website: http://www.sbi-alapromo.co.jp

## Sources

- Official website: http://www.sbi-alapromo.co.jp
- ClinicalTrials.gov: trials led by SBI ALApharma Canada, Inc.: https://clinicaltrials.gov/search?lead=SBI%20ALApharma%20Canada%2C%20Inc.
- Wikidata: https://www.wikidata.org/wiki/Q11242594

## Connected records

- cancers: [Bladder & urothelial cancer](https://onco.cc/cancers/urothelial/), [Glioma & glioblastoma](https://onco.cc/cancers/glioblastoma/)
- technologies: [Cystoscopy, blue-light imaging & TURBT](https://onco.cc/technologies/cystoscopy-turbt/), [Fluorescence-guided surgery](https://onco.cc/technologies/fluorescence-guided-surgery/)
- drugs: [Aminolevulinic acid (topical, for photodynamic therapy)](https://onco.cc/drugs/aminolevulinic-acid/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)

---
JSON: https://onco.cc/api/v1/entities/sbi-pharmaceuticals.json